Indoco Remedies receives tentative ANDA approval from USFDA for Canagliflozin Tablets

Indoco wins the SAP ACE Award 2023 in the 'GAME CHANGER' category

Indoco Analytical Solutions (IAS) receives the 'Best Customer Service Provider - Pharma and Healthcare' award

Indoco's Goa facility - Plant III receives EU GMP certification from the German Health Authority

Indoco wins the Vibrant Goa Inspiration Award

Indoco's Baddi facility (Unit I) receives GMP certification from EU Health Authority

Indoco wins the Excellence in Anti-Counterfeiting Packaging Award

Indoco's Baddi facility (Unit III) receives EUGMP certification from Health Authority of Germany

Indoco acquires 85 % equity stake in US based FPP Holding Company, LLC.

Indoco receives EIR for its manufacturing facility in Goa (Plant I)

Excellence in Pharma Supply Chain Management award for Indoco!

Indoco wins the "GOA BEST EMPLOYER BRAND AWARD 2023"

Indoco wins the Lead 50 (Next) Supply Chain Award

Sundeep Sir inaugurates the new OSD block at Waluj plant

ATM honoured with the Champion brand of the year with a Silver Impact Award by Pronto Consult Consumer Award

Indoco completed 75 years of excellence on 23^rd August, 2022

Indoco bags the Digital Pharma Marketing Excellence Award for being the 'Digitally Visible Company of the Year' at DIGIPHARMAX 2022

EDQM grants CEP for Lacosamide API to Indoco

Indoco receives the 'IDMA Margi Patel Choksi Memorial Best Patent Awards 2019-2021'

Goa plant I completes 25 years of excellence in April 2022

Indoco Remedies receives USFDA approval for Lacosamide Injection USP

Indoco Remedies receives USFDA approval for Lacosamide Tablets

Indoco ranks 24^th in the Indian Pharma Market (IPM) for the month of January'22. The Company's value growth of 44.9% is higher than the industry growth of 13.9%. There has been an impressive spur in volumes (unit) growth of 34.1%

CYCLOPAM wins the PCCA 'Platinum Brand Impact Award' for March 2021 presented by Pronto Consult Consumer Award

KARVOL PLUS wins the PCCA 'Best Innovative Campaign' Award for January 2021 presented by Pronto Consult Consumer Award

Indoco announces the launch of Brinzolamide Ophthalmic Suspension 1% in the US market by Teva Pharmaceuticals

Indoco wins major tenders in Germany for Allopurinol Tablets

Indoco's Kidodent receives the 'Most Trusted Pediatric Toothpaste for Regular Use' Award at the Pediatrics Conference 2020 organised by CIMS Medica India

Baddi plant I inaugurates new Liquid Block

Indoco receives USFDA approval for Apixaban Tablets 2.5 mg & 5 mg

Indoco awarded with the IDMA Formulations Best Patent Award 2018-19 for 2 formulation patents – Diclofenac & Quetiapine

Olopatadine ANDA filed from Indoco's Goa Plant II receives USFDA approval

AnaCipher Clinical Research receives BE study approval from WHO

First consignment of Glycopyrrolate Injection dispatched from Goa Plant II for launch in USA

Indoco receives USFDA approval for Succinylcholine Chloride Injection USP

Indoco receives USFDA approval for Olanzapine Tablets

Indoco commissions New API manufacturing facility at Patalganga

Indoco's Goa Plant II & III clears USFDA inspection

Indoco's API manufacturing facilities at Patalganga and Rabale successfully clear USFDA inspection

Indoco's API Patalganga site receives Renewed Accreditation Certificate from The Pharmaceuticals and Medical Devices Agency (PMDA), Japan

Indoco receives the IDMA Best Indian Patent Award for five API Process Patents

Indoco's Goa plant III receives EU GMP certification

Indoco receives the Express Pharma Export Excellence Award 2017

Indoco receives UKMHRA approval for solid dosages Plant I in Goa

Indoco receives the IDMA Best Patent Award for four API Process Patents

Indoco receives patent grant for Linezolid & Brinzolamide (FDFs) from United States Patent and Trademark Office (USPTO)

Indoco Honoured with the IDMA Best Patent Award for Three International Patents

Indoco achieves a milestone of Rs.1000 Crs

Indoco acquires Oral Solid Dosage manufacturing facility in Baddi from Micro Labs Ltd., Bangalore

Indoco's Allopurinol ANDA gets USFDA approval

Indoco climbs 187 ranks up - Fortune India

Indoco receives USFDA approval for solid dosages Plant I in Goa

Indoco honoured with the 'Best Patent Award' by PHARMEXCIL in the Bulk Drugs / API category

Indoco wins IDMA Patent Appreciation Award for Betaxolol

Indoco acquires Piramal's Clinical Research division

Inauguration of New GLP Analytical facility for Formulation

US-FDA approves Sterile (Plant II) and Solid Dosages (Plant III) facilities in Goa

IDMA Best Patent Award for Tazarotene & Adapalene

Indoco announced the signing of an agreement with DSM, a € 9 billion Company, for commercial cooperation for Active Pharmaceutical Ingredients (APIs). Indoco and DSM have formed a strategic alliance, wherein DSM shall be marketing and selling the APIs manufactured by INDOCO

Innovation in Quality Award at CPhI Pharma Awards

Indoco received the Silver Quality Excellence Award for Sterile Manufacturing Facility in Goa and Solid Dosages Facility in Baddi (Himachal\Pradesh) at IDMA's Golden Jubilee celebrations

Indoco Remedies teams up with ASPEN, South Africa by licensing out intellectual property (dossiers) for marketing its products in emerging markets covering 30 countries, including SA, Brazil, Mexico, Venezuela, Russia & Australia

Indoco Remedies licenses out technology to Watson Pharmaceuticals Inc. USA. Under the terms of profit sharing agreement, Indoco will develop, manufacture and supply a basket of sterile products to Watson for the US market

UK-MHRA approval for the Solid Oral Dosage forms at Baddi Plant

Export sales exceeded Rs. 1 Billion in the FY 08-09

Successfully faced Slovenia audit for the Sterile Facility at Goa Plant II for the Injections Area

ANVISA (Brazil) approval for the Solid Dosage facility at GOA Plant I

Commencement of exports to the US markets

Launch of Warren-Excel and Spera - two specialty marketing divisions

US-FDA approval for Ophthalmic facility, Plant-II in GOA

Contract signed for supply of 18 generic products to German Market

2 ANDAs filed with USFDA

Commencement of liquid manufacturing facility at Baddi, Himachal Pradesh

New R&D Centre at Rabale, near Mumbai becomes functional

Solid Dosage facility at Goa Plant I re-inspected & approved by UK-MHRA

UK-MHRA approval for Creams & Ointments facility

Darmstadt-Germany approves our Goa facility for Solid Dosage manufacturing

Acquisition of LaNOVA Chem Pvt. Ltd. with its brand new API manufacturing facility of international standards

Launch of Surge - a specialty marketing division

First ANDA filed on the basis of Exhibit batches manufactured in our sterile facility in Goa

Development Contracts for injectable products signed with a US Company

Tablet capacity doubled by commissioning an extended facility in the existing UK-MHRA approved plant

Shares of the Company listed on BSE and NSE

First Contract for Development services with US Company

Karvol brand acquisition from Solvay Pharmaceuticals Pvt. Ltd

Four Patent applications filed

Company jumps five ranks in two yrs in the ORG-IMS Retail Audit

UK-MHRA approval for the Solid Dosage facility at Plant I

Exports to regulated markets commence

First contract for Dossier Development with European company

Domestic Marketing makes a foray into the lifestyle segment

State-of-the-art sterile facility, Plant II commissioned at Verna Goa

New Corporate Office at Indoco House

Acquisition of Warren. Indoco makes presence in Ophthalmic & Dental Segments

Turnover crosses Rs. 100 cr.

Commencement of production in Goa Plant I

R&D recognized by DSIR

Turnover crosses Rs. 10 Cr.

Inauguration of new office at Andheri

Turnover crosses Rs. 1 Cr.

New manufacturing unit at Andheri

Suresh G. Kare takes over as Managing Director

23rd August 1947, Indoco Remedies Limited was formed